Genetic testing will help in the detection of lung cancer
U.S. researchers have discovered a test may be useful in predicting who suffer lung cancer killer.
The researchers said the test, which reveals the lethal genes in the lungs of people from the groups most vulnerable to lung cancer may help in identifying those who may already be infected the disease.
But researchers also said that the test is not accurate, so far, enough to be widely used, but it might replace the X-ray risky and costly.
The head of the Action Team program manager Stephen Plinski lung cancer at the Institute of Lovelace Respiratory Research in Albuquerque, New Mexico, “Unless we examine a number of times the lung X-ray to detect any tumors, there is emerging, we have no means to test those most at risk of lung cancer to be diagnosed with the disease at a later stage. ”
He added in a statement: “When proficiency testing and to ensure the accuracy of such tests had been successful in detecting lung cancer early enough for treatment.”
The Plinski and the number of his colleagues in the March 15 issue of the journal Cancer Research, which conducted the test succeeded in detecting 65% of the cases that have been symptoms of lung cancer in 18 months but at the same time and the wrong type 35% of the volunteers not infected with cancer patients as the .
The test examines the DNA in lung cells in sputum, and it is known that some genes are discouraged in the lung cancer.
It remains alive for more than five years, only 15% of patients with lung cancer and is due in part to the fact that the disease do not show many of the symptoms early and most people are not only diagnosed with the cancer has spread in the body.
Plinski said, “because most people are diagnosed with the disease at a time when the cancer is at an advanced stage, the surgical intervention and treatment of chemotherapy and radiation does not benefit them, therefore, the survival rate after diagnosis is only 13 months.”
Source: Reuters
Trojan horse for cancer treatment
Researchers at the Massachusetts Institute of Technology to develop accurate cell could infiltrate into the cancer cells, and then close the bloody Ooeitha release doses of anti-cancer drugs.
The cell has proved accurate, measured by the dimensions of the parts of one million square meter (nm) are proving effective against skin cancer and one of lung cancer at the types of mice.
The dual strategy, ie, cut off supplies of blood to cancer cells by destroying drugs, almost impossible, where the drug can not be delivered to the heart of the fabric made bags of blood.
The medical team has been designed into a cell in the heart of football again, with each containing a different kind of medicine.
Has created a way to prevent the immune system to detect the cell minute, also made the small size of the adequacy of infiltration into the cancer cells, but more than that into the other tissues.
Experience has shown that the drug on mice, which cut off blood vessels free of outer membrane disintegration, which closed on cell cancer cells start firing accurate chemotherapy like traditional remedies, but without damage to cells adjacent to cancer.
Has shrunk the cancerous tumor in the mice remained 8 out of ten survive for more than 65 days.
Did not live mice received the best possible treatment traditionally only 30 days, while the remaining did not exceed a period of 20 days without treatment.
The results of micro-cell cancer of the skin against the best of them against lung cancer, which shows should be adjusted according to different types of cancer.
He said a member of the medical team that will not stop research, but will continue on the basis of the results obtained.
Said Dr. Volkman presence of the Children’s Hospital in Boston it was “a smart technology to attack the cancer cells in two respects, they are cut off the blood supply and then chemically exterminated.”
The cell has been proven accurate, and the dimensions measured by the one million parts of a meter (nm) are proving effective against skin cancer and one of lung cancer at the kinds of mice.
The dual strategy, namely to cut the supply of blood to cancer cells by destroying drugs, almost impossible, where the drug can not be delivered to the heart of the fabric made bags of blood.
The medical team has been designed into a cell in the heart of football again, with each containing a different kind of medicine.
Has created a way to prevent the immune system to detect the cell minute, also made the small size of the adequacy of infiltration into the cancer cells, but more than that into the other tissues.
Experience has shown that the drug on mice, which cut off blood vessels free of outer membrane disintegration, which closed on cell cancer cells start firing accurate chemotherapy like traditional remedies, but without damage to cells adjacent to cancer.
Has shrunk the cancerous tumor in the mice remained 8 out of ten survive for more than 65 days.
Did not live mice received the best possible treatment traditionally only 30 days, while the remaining did not exceed a period of 20 days without treatment.
The results of micro-cell cancer of the skin against the best of them against lung cancer, which shows should be adjusted according to different types of cancer.
He said a member of the medical team that will not stop research, but will continue on the basis of the results obtained.
Said Dr. Volkman presence of the Children’s Hospital in Boston it was “a smart technology to attack the cancer cells in two respects, they are cut off the blood supply and then chemically exterminated.”
Copyright 2009
This Informations Collected And Translated From Arabic Language By Mesothelioma Guide
New Drug Study for Abdominal Mesothelioma
* Response rate among patients was 15 percent.
* The control rate of the disease for patients while on the medication was 50 percent.
* The median time to disease progression was 10.4 months.
* The median survival time was 26.8 months.
* The mesothelioma study involved 20 patients suffering from the condition.
In addition to the two drugs, the patients received dexamethasone, folic acid and vitamin B12. The study was conducted by researchers involved in a multi-center U.S. trial. Researchers expect to continue studying the drugsà effects on abdominal mesothelioma patients to determine if the treatment can be improved.
What is Abdominal Mesothelioma?
Abdominal mesothelioma is an extremely rare form of mesothelioma cancer. Commonly described as peritoneal mesothelioma, the cancer affects the abdominal lining, which is also known as the peritoneum. The serous membrane contains the parietal peritoneum, which continues on to the visceral peritoneum, which lines the organs; all of this is located in the abdominal cavity. With abdominal mesothelioma, the visceral and parietal peritoneum linings are affected with the development of cancerous cells.
Most often, abdominal cancer occurs when an individual first develops pleural mesothelioma, which is when the lining of the lung develops cancerous cells after inhalation of asbestos. Pleural mesothelioma can then spread to the peritoneal cavity and cause peritoneal mesothelioma, which accounts for less than one-third of all mesothelioma diagnoses.
How Does Someone Develop Abdominal Mesothelioma?
Abdominal, or peritoneal, mesothelioma is caused through the inhalation of asbestos fibers or asbestos dust. Asbestos is a material that is derived from vermiculite, a mineral that was mined heavily in the United States and around the world in the 20th century. Asbestos was most commonly used as an insulation within the construction industry because it was flame resistant and was developed at inexpensive prices.
An array of mild to severe mesothelioma symptoms exist, including:
* shortness of breath.
* inability to breath.
* fatigue.
* wheezing or severe cough.
Although, these symptoms are considered generalized for mesothelioma and do not represent specific types of the cancer. Additionally, there are a specific set of symptoms associated with abdominal mesothelioma. These symptoms are as follows:
* weight loss.
* abdominal swelling, which can be caused by ascites or the buildup of fluid in the abdominal cavity.
* bowel obstruction.
* fever.
* anemia.
* blood clotting.
* trouble swallowing.
* swelling of neck and face.
Abdominal Mesothelioma Treatment
Abdominal mesothelioma treatments commonly consist of surgical procedures to remove the infected cancerous areas. Often, the main surgery involved with peritoneal mesothelioma is known as cytoreductive surgery. While many individuals will receive specific treatments based on their case, the surgery usually is coupled with a chemotherapy treatment — this treatment is often called the perioperative intraperitoneal chemotherapy and has been shown to slightly improve the median survival rate.
Obtaining Peritoneal Mesothelioma Legal Help
Individuals who have been diagnosed with peritoneal mesothelioma or any similar form of mesothelioma cancer are advised to locate an experienced mesothelioma attorney. Individuals who have been exposed to mesothelioma should contact a medical professional immediately because of the dangers that exist to even limited exposure to asbestos. These individuals may be able to receive monetary compensation for the extremely costly medical bills associated with abdominal mesothelioma.
It is especially important for an individual to seek legal counsel for their mesothelioma lawsuit if they were an employee within the metal, mining, maritime, construction and welding industries.
About the Author
Learn more about abdominal mesothelioma and treatments at http://mesothelioma.legalview.com or visit http://www.LegalView.com/ . Additionally, LegalView offers information on other various legal issues such as the Cipro risks or the latest on truck accident lawsuits.
-
Translation :
Translator
